Survey of canine use and safety of isoxazoline parasiticides

Shady – Diabetes
June 30, 2020

Survey of canine use and safety of isoxazoline parasiticides

By Valerie Palmieri, W. Jean Dodds, Judy Morgan, Elizabeth Carney, Herbert A. Fritsche, Jaclyn Jeffrey, Rowan Bullock, Jon P. Kimball

June 2, 2020

Abstract

A veterinarian and pet owner survey (Project Jake) examined the use and safety of isoxazoline parasiticides given to dogs. Data were received during August 1–31, 2018 from a total of 2,751 survey responses. Forty-two percent (1,157) reported no flea treatment or adverse events (AE), while 58% (1594) had been treated with some parasiticide for flea control, and of those that received a parasiticide, the majority, or 83% (1,325), received an isooxazoline. When any flea treatment was given, AE were reported for 66.6% of respondents, with no apparent AE noted for 36.1%. Please click here for link to the rest of the article at Wiley Online Library.

Leave a Reply

Your email address will not be published. Required fields are marked *